Inspiratory Muscle Training During Pulmonary Rehabilitation in COPD
Overview
Demonstrate that IMT associated with a conventional pulmonary rehabilitation program allows a significant improvement of dyspnea in subjects with severe or very severe COPD than a conventional pulmonary rehabilitation program alone.
Full Title of Study: “Effects of Inspiratory Muscle Training (IMT) on Dyspnea in COPD During Pulmonary Rehabilitation: Randomized Controlled Trial”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Supportive Care
- Masking: None (Open Label)
- Study Primary Completion Date: October 2016
Interventions
- Other: Inspiratory muscle training
- Inspiratory muscle training
Arms, Groups and Cohorts
- No Intervention: Standard
- conventional pulmonary rehabilitation
- Experimental: Inspiratory muscle training
- Inspiratory muscle training associated with a conventional pulmonary rehabilitation
Clinical Trial Outcome Measures
Primary Measures
- Dyspnea measure
- Time Frame: 21 – 4 days / +7 jours
- Measure of dyspnea with the Multidimensional Dyspnea Profile (MDP) questionnaire.
Secondary Measures
- PI max variation
- Time Frame: 21 – 4 days / +7 days
- Measure of PI max variation with MicroRPM
- CI variation
- Time Frame: 21 – 4 days / +7 days
- Measure of CI variation with spirobank II
- Dyspnea measure
- Time Frame: 21 – 4 days / +7 days
- Meausre of dyspnea with London Chest of Activity Daily Living (LCADL)
Participating in This Clinical Trial
Inclusion Criteria
- Patients with COPD stage 3 or 4 – Hospitalized in the pulmonary rehabilitation unit in the hospital of Morlaix, with a 3 weeks pulmonary rehabilitation course; Exclusion Criteria:
- FEV ≥ 50% – Pneumonectomy, Lobectomy less than 6 months – Patient with risk of spontaneous pneumothorax or rib fracture
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- University Hospital, Brest
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.